MOESM1 of Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial Takahiro Sawada Hideo Tsubata Naoko Hashimoto Michinori Takabe Taishi Miyata Kosuke Aoki Soichiro Yamashita Shogo Oishi Tsuyoshi Osue Kiminobu Yokoi Yasue Tsukishiro Tetsuari Onishi Akira Shimane Yasuyo Taniguchi Yoshinori Yasaka Takeshi Ohara Hiroya Kawai Mitsuhiro Yokoyama 10.6084/m9.figshare.c.3606221_D2.v1 https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Effects_of_6-month_eicosapentaenoic_acid_treatment_on_postprandial_hyperglycemia_hyperlipidemia_insulin_secretion_ability_and_concomitant_endothelial_dysfunction_among_newly-diagnosed_impaired_glucose_metabolism_patients_with_coronary_artery_dis/4348037 Additional file 1: Table S1. Multiple regression analysis for predicting incremental glucose peak improvement. 2016-08-26 05:00:00 Eicosapentaenoic acid Impaired glucose metabolism Postprandial hyperglycemia Postprandial insulin secretion Postprandial hypertriglyceridemia Endothelial dysfunction